Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 2Withdrawn 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Multiple Myeloma 22Lymphoma 16Neoplasms, Plasma Cell 12Lymphoma, Non-Hodgkin 11Lymphoma, Large B-Cell, Diffuse 8Neuroblastoma 7Lymphoma, Mantle-Cell 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Hodgkin Disease 6Myelodysplastic Syndromes 5Lymphoma, Large-Cell, Immunoblastic 5Leukemia 5Burkitt Lymphoma 5Lymphoma, Follicular 4Leukemia, Lymphocytic, Chronic, B-Cell 4Recurrence 3Lymphoma, B-Cell, Marginal Zone 3Leukemia, Myeloid, Chronic-Phase 3Leukemia, Myeloid, Acute 3Sarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Neuroectodermal Tumors, Primitive 2Medulloblastoma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Biphenotypic, Acute 2Dendritic Cell Sarcoma, Interdigitating 2Brain Neoplasms 2

Interventions

Melphalan 2Carboplatin 2sodium thiosulfate 1Verteporfin 1Thiotepa 1TH 302 1Surveys and Questionnaires 1Mannitol 1Etoposide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Neuroectodermal Tumors, Primitive × Melphalan × Clear all
NCT00983398 2021-10-26

Melphalan, Carboplatin, Mannitol, and Sodium Thiosulfate in Treating Patients With Recurrent or Progressive CNS Embryonal or Germ Cell Tumors

OHSU Knight Cancer Institute

Phase 1/2 Unknown
17 enrolled
CNS

Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Neuroectodermal Tumors, Primitive

NCT00180791 2007-09-18

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Unknown
71 enrolled
CNS

Brain Neoplasms, Medulloblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡